Table 1.

Clinical, microbiological and sampling data on pwCF in this study prior to and after ETI therapy. Numbers are reported means. NA=not applicable, +/− = Standard Deviation of the mean.

	Prior to ETI	Post ETI	Delta
Number of subjects	24	24	NA
% Male	NA	0.54	NA
Average age (from range)	32.50	33.00	0.50
FEV1%-predicted	50.21 (+/−17.8)	65.86 (+/−18.73)	15.65
FVC	71.83 (+/−20.0)	81.95 (+/−18.36)	10.12
BMI	22.14 (+/−3.44)	23.63 (+/−3.31)	1.49
Height (cm)	166.58	166.39	−0.19
# Days on ETI	NA	149.71 (+/−81.17)	NA
# Days between samples	NA	201.79 (+/−107.97)	NA
% Pseudomonas by culture	70.00	84.00	14.00
Exacerbations per year	2.63	2.45	−0.17
% Pancreatic sufficient	NA	0.04	NA